FEATURED

Lexicon Secures $1 Billion Deal with Novo Nordisk for Obesity Candidate
Lexicon Pharmaceuticals announced an exclusive worldwide licensing agreement with Novo Nordisk for LX9851, a first-in-class oral non-incretin therapy in development for
DEALS

Lexicon Secures $1 Billion Deal with Novo Nordisk for Obesity Candidate
Lexicon Pharmaceuticals announced an exclusive worldwide licensing agreement with Novo Nordisk for LX9851, a first-in-class oral non-incretin therapy in development for
PRESS RELEASES

Microglia Demyelination Shields CNS from Axonal Damage
A groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
EDITOR’S PICKS

Application-driven Enzymes to Expedite Pharma Processes
Application-driven enzyme engineering is a new technology created by combining in silico modelling and wet-lab based enzyme screening that is
RESOURCES

CTAT Conjugation for Diagnostics & Antibody Drug Conjugates (ADC’s)
The CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A Biosynth Case Study This
MANUFACTURING PROJECTS

MSD Acquires WuXi Vaccines Facility in Dundalk for €500m
In a significant acquisition move, pharmaceutical giant MSD has agreed to acquire the WuXi Vaccines manufacturing facility in Dundalk, Ireland.
CLINICAL TRIALS

Lilly’s Lepodisiran Slashes Heart Disease Risk Factor by 94% in Phase 2 Trial
Eli Lilly and Company announced groundbreaking Phase 2 results for its investigational siRNA therapy lepodisiran, which reduced lipoprotein(a) [Lp(a)] levels
REGULATORY

Novartis Secures Landmark FDA Approval for Fabhalta® in Rare Kidney Disease
Novartis has received its third U.S. Food and Drug Administration (FDA) approval for Fabhalta® (iptacopan), marking a major milestone as
SELECTED PRODUCTS

Metabolites & Impurities for Pharmaceutical Research
Expert Synthesis Solutions (ESS) is a globally trusted partner for pharmaceutical R&D professionals offering a unique catalog of high-purity metabolites,